Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-16

Clinical Trial Update: Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating catheter ablation for recently diagnosed paroxysmal atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Valley Health System | Conditions: Atrial Fibrillation | Phase 4 | Status: WITHDRAWN